Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyriu… Ended

2024-515888-54-00 Myopia in children 5 2022-06-29
A phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine… Ended

2024-516315-24-00 myopia 5 2022-05-27
A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended

2023-507131-38-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2022-05-16
Extension Study to Evaluate the Long-Term Outcomes of Paediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe… Ended

2024-513231-24-00 Retinopathy of prematurity (ROP) 5 2022-03-22
Postmarketing Parallel Randomized Clinical Trial to Determine the Efficacy and Safety of Atropine and DIMS Lenses in the Control of Myopia i… Ended

2024-514651-15-00 Myopia 6 2022-02-16
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System with Ranibizumab in Patients … Ended

2023-507130-24-00 Neovascular age-related macular degeneration (nAMD) 5 2021-10-22
Low-dose AtropIne for Myopia control in children Ended

2024-513091-17-00 Progressive myopia 5 2021-09-29
Safety and efficacy of a bilateral single subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia in… Ended

2024-515553-17-00 CNGA3-linked achromatopsia 9 2021-03-11
Long-term need of Ranibizumab injections with or without early targeted peripheral laser photocoagulation for treatment of macular edema due… Ended

2023-507816-11-00 Macular edema due to central retinal vein occlusion 5 2020-08-17
PIGMENT – PDE6A gene therapy for retinitis pigmentosa Ended

2024-517924-20-00 PDE6A-linked Retinitis Pigmentosa 7 2019-09-24
The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With … Ended

2023-506317-22-00 Neovascular (wet) age-related macular degeneration (AMD 4 2019-09-18
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension Ended

2024-519595-87-00 Ocular hypertension 5 2015-12-15
Evaluation of the effects of bosentan in the management of patients in the acute phase of acute anterior ischemic optic neuropathy. Ended

2024-518345-21-00 early stage of acute non-arteritic anterior ischemic op 5 2015-07-31
Phase I/II Follow-up Study of SAR422459 in Patients with Stargardt’s Macular Degeneration Ended

2024-513501-31-00 Congenital, hereditary and neonatal diseases 4 2013-05-30
RB SFCE 2009 : Adjuvant treatment in extensive unilateral retinoblastoma primary enucleated Ended

2024-514844-10-00 Retinoblastoma 4 2010-03-18
Comparative clinical trial of efficacy and satisfaction of 2% gel lidocaine versus tetracaine/oxybuprocaine anesthetic eye drops in patients… Halted

2023-505131-13-01 Glaucoma 6 2024-01-11
An open-label, single group, single-dose clinical study to evaluate the usability of the pre-filled syringe (PFS) of SB11 in trial participa… Ended

2025-520599-24-00 Neovascular Age-Related Macular Degeneration (AMD), Ma 4 2026-03-27
Pharmacodynamics of a Fixed dose combination of 0.34% tropicamide and 2.5% phenylephrine hydrochloride, eye drop, Solution Ended

2024-517456-35-00 to obtain pre-operative mydriasis or for diagnostic pur 9 2025-10-08
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food… Ended

2024-515078-28-00 Diabetic Retinopathy 3 2025-04-16
Efficacy of tocilizumab in the treatment of acute anterior ischemic optic neuropathy optic neuropathy in Horton's disease Ended

2024-519977-20-00 Acute Anterior Ischemic Optic Neuropathy associated wit 4 2025-01-27
Two initial faricimab loading doses in treatment-naive neovascular AMD Ended

2024-514408-15-00 Neovascular age-related macular degeneration 6 2024-11-14
Multicenter randomized controlled trial of the value of intravitreal anti-VEGF injections as initial then adjuvant treatment in Coats' disea… Ended

2024-517036-21-00 Coats' disease 4 2024-11-06
A Safety and Tolerability Study of VRDN-001 in Persons with Thyroid Eye Disease (TED) Ended

2023-507563-19-00 Thyroid eye disease 5 2024-11-05
Aflibercept 8mg for high-frequent Faricimab and prior Aflibercept 2mg treated Neovascular age-related macular degeneration: a monocenter, si… Ended

2024-515497-26-00 Neovascular age-related macular degeneration 11 2024-10-24